tirzepatide obstructive sleep apnea fda approval 2024 approves first medication for — which also promotes weight loss FDA Approves Zepbound for Sleep

warm, low-fat, mild often tolerated even on nausea days Half a cup of Greek yoghurt + one tablespoon of hemp seeds ~18g protein, ~200 kcal Small portion of smoked salmon on a half-slice of wholegrain bread ~15g protein, ~180 kcal Soft, Bland, and Cold Foods for Injection-Day Nausea Many people on GLP-1 medications experience nausea in the 2448 hours after their injection particularly in the early dose-escalation period

Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Liraglutide (Brand names: Victoza, Saxenda) Features: Daily injection Victoza approved for type 2 diabetes, Saxenda for weight management Benefits: Moderate weight loss Improved blood sugar control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements

Retatrutide Therapy A triple-action investigational peptide designed to interact with GLP-1, GIP, and glucagon receptors Your provider will review benefits, risks, and eligibility before recommending any treatment

Akimoto, H

doi: 10.1186/s12902-025-01996-z